Related Experiment Video
Updated: Aug 8, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Acute organ injury and long-term sequelae of severe pneumococcal infections
Katherine L Kruckow1, Kevin Zhao2, Dawn M E Bowdish2
1Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Insights
Streptococcus pneumoniae (Spn) causes severe illness and long-term health issues. Survivors face reduced quality of life and life expectancy due to organ damage from pneumococcal disease.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Streptococcus pneumoniae (Spn) is a significant global health concern.
- It causes serious conditions like pneumonia, meningitis, and sepsis.
- Acute Spn infections lead to organ damage with lasting effects.
Purpose of the Study:
- To review evidence on long-term sequelae of pneumococcal disease.
- To highlight the impact of Spn infection on survivors' quality of life and life expectancy.
Main Methods:
- Literature review of studies on pneumococcal disease outcomes.
- Analysis of data on organ damage and long-term morbidities post-infection.
Main Results:
- Pneumococcal infections cause organ damage through bacterial toxins, stress, and inflammation.
- Survivors experience new or worsened chronic conditions (COPD, heart disease, neurological impairments).
- Current mortality statistics underestimate the long-term impact of pneumococcal disease.
Conclusions:
- Damage from acute Spn infection results in chronic sequelae.
- These sequelae significantly reduce survivors' quality of life and life expectancy.
- A comprehensive understanding of Spn's long-term effects is crucial for public health strategies.
Abstract:
Streptococcus pneumoniae (Spn) is a major public health problem, as it is a main cause of otitis media, community-acquired pneumonia, bacteremia, sepsis, and meningitis. Acute episodes of pneumococcal disease have been demonstrated to cause organ damage with lingering negative consequences. Cytotoxic products released by the bacterium, biomechanical and physiological stress resulting from infection, and the corresponding inflammatory response together contribute to organ damage accrued during infection. The collective result of this damage can be acutely life-threatening, but among survivors, it also contributes to the long-lasting sequelae of pneumococcal disease. These include the development of new morbidities or exacerbation of pre-existing conditions such as COPD, heart disease, and neurological impairments. Currently, pneumonia is ranked as the 9th leading cause of death, but this estimate only considers short-term mortality and likely underestimates the true long-term impact of disease. Herein, we review the data that indicates damage incurred during acute pneumococcal infection can result in long-term sequelae which reduces quality of life and life expectancy among pneumococcal disease survivors.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: